NEUROCRINE BIOSCIENCES INC
NBIXLatest QuantConomy context for NBIX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
NEUROCRINE BIOSCIENCES INC
QuantConomy has a structured record for NBIX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- NBIX
- Name
- NEUROCRINE BIOSCIENCES INC
- Coverage
- 3 market/data records
- Sources
- alpaca fmp alphavantage sec nasdaq openfigi
Recent signals for NBIX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| standard proposed sale | slightly bearish | 30 | Jul 7, 08:40 PM | INGRID DELAET filed Form 144 to sell NBIX shares ($2.54M) - 14,571 shares - expected around 7/7/2026 - [very weak slightly bearish signal - supply pressure] |
| earnings release | neutral | 40 | Feb 11, 12:00 AM | NBIX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-11. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| large sale | slightly bullish | 33 | Jun 4, 10:04 PM | Cooke Julie exercised options for NBIX shares ($2.03M) - 24965 shares - [very weak slightly bullish signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| NBIX | NASDAQ | alpaca | Neurocrine Biosciences, Inc. Common Stock |
| NBIX | NASDAQ | fmp | Neurocrine Biosciences, Inc. |
| NBIX | NASDAQ | alphavantage | Neurocrine Biosciences Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Delaet Ingrid | Chief Regulatory Officer | exercise | 4,367 | $106.02 | $462,989 | 4 on EDGAR |
| Jul 9, 2026 | Lippoldt Darin | Chief Legal Officer | exercise | 10,000 | $81.49 | $814,900 | 4 on EDGAR |
| Jul 7, 2026 | Delaet Ingrid | Chief Regulatory Officer | exercise | 3,401 | $103.52 | $352,072 | 4 on EDGAR |
| Jun 5, 2026 | SHERWIN STEPHEN A | Insider | exercise | 15,000 | $53.64 | $804,600 | 4 on EDGAR |
| Jun 5, 2026 | Onyia Jude | Chief Scientific Officer | gift | 2,441 | $0.00 | $0 | 4 on EDGAR |
| Jun 4, 2026 | Norwalk Leslie V | Insider | sale | 1,250 | $168.06 | $210,072 | 4 on EDGAR |
| Jun 2, 2026 | Cooke Julie | Chief Human Resources Officer | exercise | 24,965 | $81.49 | $2,034,398 | 4 on EDGAR |
| Jun 2, 2026 | Keswani Sanjay Chandru | Chief Medical Officer | exercise | 3,212 | $0.00 | $0 | 4 on EDGAR |
| Jun 1, 2026 | Onyia Jude | Chief Scientific Officer | exercise | 11,000 | $84.74 | $932,140 | 4 on EDGAR |
| May 29, 2026 | Delaet Ingrid | Chief Regulatory Officer | exercise | 2,261 | $79.02 | $178,664 | 4 on EDGAR |
| May 27, 2026 | Sharp Shalini | Insider | grant | 2,567 | — | — | 4 on EDGAR |
| May 27, 2026 | GORMAN KEVIN CHARLES | Insider | grant | 5,248 | — | — | 4 on EDGAR |
| May 27, 2026 | MORROW GEORGE J | Insider | grant | 2,567 | — | — | 4 on EDGAR |
| May 27, 2026 | POPS RICHARD F | Insider | grant | 2,567 | — | — | 4 on EDGAR |
| May 27, 2026 | Onyia Jude | Chief Scientific Officer | exercise | 11,000 | $84.74 | $932,140 | 4 on EDGAR |
| May 27, 2026 | POON CHRISTINE A | Insider | grant | 2,567 | — | — | 4 on EDGAR |
| May 27, 2026 | SHERWIN STEPHEN A | Insider | grant | 2,567 | — | — | 4 on EDGAR |
| May 27, 2026 | RASTETTER WILLIAM H | Insider | grant | 2,567 | — | — | 4 on EDGAR |
| May 27, 2026 | Mercier Johanna | Insider | grant | 2,567 | — | — | 4 on EDGAR |
| May 27, 2026 | LYONS GARY A | Insider | grant | 1,284 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query NBIX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access